# Disc Medicine Shares APOLLO Trial Results

> Disc Medicine reports bitopertin trial success for EPP treatment.
- Title: Disc Medicine Shares APOLLO Trial Results · Seekingalpha
- Summary: Disc Medicine reports bitopertin trial success for EPP treatment. Disc Medicine Inc. (IRON) announced positive top-line results from its APOLLO Phase III…
- Keywords: disc medicine, iron, apollo, bitopertin, epp, phase iii trial, money, business, Disc, Medicine, Shares, Trial
- Source: Seekingalpha — https://seekingalpha.com/article/4956111-disc-medicine-inc-iron-discusses-topline-results-of-apollo-phase-iii-trial-of-bitopertin-in
- Author: SA Transcripts
- Published: 2026-10-21T23:05:48+00:00
- Read time: 1 min
- Topics: disc medicine, iron, apollo, bitopertin, epp, phase iii trial, money, business
## Disc Medicine Inc.
Disc Medicine Inc. (IRON) published a slide deck discussing top-line results from its APOLLO Phase III trial of bitopertin for EPP.
## APOLLO Phase III Trial
The trial tested bitopertin for EPP, a rare genetic disorder affecting the liver.
## Topline Results
Disc Medicine reported positive top-line results from the APOLLO Phase III trial of bitopertin for EPP.
## Key takeaway

Disc Medicine Inc. (IRON) announced positive top-line results from its APOLLO Phase III trial of bitopertin for EPP.